Zobrazeno 1 - 10
of 123
pro vyhledávání: '"A. Pencz"'
Autor:
Sara Kuruvilla, M., Liu, Geoffrey, Syed, Iqra, Gwadry-Sridhar, Femida, Sheffield, Brandon S., Sachdeva, Robin, Pencz, Alec, Zhan, Luna, Hueniken, Katrina, Patel, Devalben, Balaratnam, Karmugi, Khan, Khaleeq, Grant, Benjamin, Noy, Shawna, Singh, Karan, Liu, Linda, Rakibuz-Zaman, Muhammad, Moldaver, Daniel, Kate Shanahan, Mary, Cheema, Parneet K.
Publikováno v:
In Lung Cancer November 2022 173:58-66
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1189-1193 (2021)
This case discusses a 62-year-old woman with de novo metastatic lung adenocarcinoma (PD-L1 >50% with a KRAS G12C mutation, ALK and EGFR negative) who was on pembrolizumab for 1 year without any significant toxicity, only low-grade dermatitis and hypo
Externí odkaz:
https://doaj.org/article/b49e0bb04f7a4f9698e99c787f282971
Autor:
Jake Weddell, Emma Parr, Stacey Knight, Girish Muddegowda, Indira Natarajan, Jayan Chembala, Phillip Ferdinand, Nasar Ahmad, Zoltan Pencz, Saad Rana, Anushka Warusevitane, Changez Jadun, Sanjeev Nayak, Zafar Hashim, Albin Augustine, Julius Sim, Christine Roffe
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Mechanical thrombectomy was approved by NICE as a treatment for stroke in 2016. However, most of the evidence is from studies conducted during working hours. Only few centres in the UK perform thrombectomies out-of-hours. The Roya
Externí odkaz:
https://doaj.org/article/e6aba33e2c5a4c4bac6c4933d0f21673
Autor:
Márton Király, Konrád Sántha, Barnabás Kállai-Szabó, Kriszta Mariann Pencz, Krisztina Ludányi, Nikolett Kállai-Szabó, István Antal
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 769 (2022)
Today, in addition to many different physicochemical and pharmacological properties of the active ingredients and excipients, the developer of a pharmaceutical formulation must take into account several factors during the formulation process in order
Externí odkaz:
https://doaj.org/article/15d009d7905b4b8ba4ae6fd6c3df84a8
Autor:
Preti, Beatrice T. B.1,2 (AUTHOR), Pencz, Alec2 (AUTHOR), Cowger, Jeffery J. M.3 (AUTHOR), Vincent, Mark D.1,2 (AUTHOR), Breadner, Daniel1,2 (AUTHOR)
Publikováno v:
Case Reports in Oncology. 2021, Vol. 14 Issue 2, p1189-1193. 5p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1189-1193 (2021)
Case Reports in Oncology
Case Reports in Oncology
This case discusses a 62-year-old woman with de novo metastatic lung adenocarcinoma (PD-L1 >50% with a KRAS G12C mutation, ALK and EGFR negative) who was on pembrolizumab for 1 year without any significant toxicity, only low-grade dermatitis and hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42eb46848a3eac851c6a3579901eef93
https://www.karger.com/Article/FullText/518313
https://www.karger.com/Article/FullText/518313
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Sara Kuruvilla, Geoffrey Liu, Iqra Syed, Femida Gwadry-Sridhar, Brandon S. Sheffield, Robin Sachdeva, Alec Pencz, Luna Zhan, Katrina Hueniken, Devalben Patel, Karmugi Balaratnam, Khaleeq Khan, Benjamin Grant, Shawna Noy, Karan Singh, Linda Liu, Muhammad Rakibuz-Zaman, Daniel Moldaver, Mary Kate Shanahan, Parneet K. Cheema
Publikováno v:
SSRN Electronic Journal.
The ADAURA trial demonstrated the benefit of adjuvant osimertinib among patients with resected, early-stage, epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). To understand the potential population impact, it is cri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291e7c9fb06a936d63122f929f9db0c6
https://doi.org/10.2139/ssrn.4161557
https://doi.org/10.2139/ssrn.4161557
Autor:
P.K. Cheema, I. Syed, F. Gwadry-Sridhar, M. Rakibuz-Zaman, R. Sachdeva, A. Pencz, L.J. Zhan, K. Hueniken, D. Patel, K. Balaratnam, K. Khan, B. Grant, S. Noy, K. Singh, B.S. Sheffield, B. Locke, D. Moldaver, M.K. Shanahan, G. Liu, M.S. Kuruvilla
Publikováno v:
Annals of Oncology. 33:S977
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::571d90d84821af72014bae6fb72d4e17
https://doi.org/10.1016/j.annonc.2022.07.1065
https://doi.org/10.1016/j.annonc.2022.07.1065